|
|
Volumn 6, Issue 5, 2004, Pages 351-356
|
|
Aspirin, NSAIDs, and COX-2 inhibitors in cardiovascular disease: possible interactions and implications for treatment of rheumatoid arthritis.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
NONSTEROID ANTIINFLAMMATORY AGENT;
PROSTAGLANDIN SYNTHASE INHIBITOR;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
COMORBIDITY;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CROSSOVER PROCEDURE;
FEMALE;
FOLLOW UP;
HOSPITALIZATION;
HUMAN;
INCIDENCE;
MALE;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
RHEUMATOID ARTHRITIS;
RISK ASSESSMENT;
TREATMENT OUTCOME;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ARTHRITIS, RHEUMATOID;
ASPIRIN;
CARDIOVASCULAR DISEASES;
COMORBIDITY;
CROSS-OVER STUDIES;
CYCLOOXYGENASE INHIBITORS;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INCIDENCE;
MALE;
RANDOMIZED CONTROLLED TRIALS;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
|
EID: 16544375000
PISSN: 15233774
EISSN: None
Source Type: Journal
DOI: 10.1007/s11926-004-0009-0 Document Type: Review |
|
Times cited : (15)
|
|
References (51)
|
